Vitrolife
215.6
SEK
+3.65 %
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
+3.65%
-2.62%
-11.86%
+23.27%
+10.73%
+10.96%
-60.04%
+10.68%
+3,413.12%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Read moreMarket cap
29.2B SEK
Turnover
12.38M SEK
Revenue
3.51B
EBIT %
-102.19 %
P/E
-
Dividend yield-%
0.46 %
Financial calendar
30/1
2025
Annual report '24
16/4
2025
Interim report Q1'25
29/4
2025
General meeting '24
ShowingAll content types
Vitrolife AB (publ): Patrik Tolf steps down as CFO of the Vitrolife Group - Helena Wennerström appointed acting CFO
Redeye: Vitrolife - Another quarter with improved organic growth
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools